Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by CAMARGOS, P. A M
Right arrow Articles by ANTUNES, C. M F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CAMARGOS, P. A M
Right arrow Articles by ANTUNES, C. M F
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1988 Oxford University Press

research-article

Risk Assessment for Acquiring Meningitis Tuberculosis among Children Not Vaccinated with BCG: A Case-Control Study

PAULO A M CAMARGOS*,{dagger}, MARK D C GUIMARAES* and CARLOS M F ANTUNES*

* Department of Pediatrics and Department of Preventive and Social Medicine, School of Medicine and Department of Paresitology, Institute for Biological Sciences, Federal University of Minas Gerais State Brazil

{dagger} Reprint requests: Departamento de Pediatria, Faculdade de Medicina, Universidade Federal de Minas Gerais, Av. Prof. Alfredo Balena 190, 30130—Belo Horizonte MG., Brasil.

This case-control study was conducted to assess the risk, among children aged 0–12 years, of developing meningitis tuberculosis (MT) associated with a lack of intradermal BCG vaccination. Cases (45) of MT admitted for treatment at the Fundacao Benjamin Guimaraes Hospital (Belo Horizonte, MG., Brazil), from 1975 to 1981, were matched for age at hospitalization, date of hospitalization and nutritional status, with two types of controls—patients with acute diarrhoea (AD) and patients with acute non-tuberculous bacterial pneumonias (BP)—admitted to the same hospital. Vaccination status was ascertained from the patients' medical records.

Results showed a risk for MT, estimated by the odds ratio, between BCG non-vaccinated and BCG vaccinated patients, of 6.7 (95% Cl 2.3–19.0) comparing cases and AD controls, of 4.0 (95% Cl 1.5–11.0) comparing cases and BP controls and 5.7 (95% Cl 2.3–14.0) comparing cases with both controls. When adjustments were made for place of residence (Metropolitan Region of Belo Horizonte and other regions of Minas Gerais State), the risks decreased to 5.2 (95% Cl 1.9–14.0 and 2.9 (95% Cl 1.2–7.3) comparing cases with AD and BP controls, respectively.

Received 1 April 1987


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
R. B. Rock, M. Olin, C. A. Baker, T. W. Molitor, and P. K. Peterson
Central Nervous System Tuberculosis: Pathogenesis and Clinical Aspects
Clin. Microbiol. Rev., April 1, 2008; 21(2): 243 - 261.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
M. P. Arbelaez, K. E Nelson, and A. Munoz
BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection
Int. J. Epidemiol., December 1, 2000; 29(6): 1085 - 1091.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.